Angela Dawn Glendenning

Title: Innovations by Angela Dawn Glendenning

Introduction

Angela Dawn Glendenning is an accomplished inventor based in Raleigh, NC. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of ocular diseases. Her innovative work has led to the development of a unique biodegradable ocular implant.

Latest Patents

Angela holds one patent titled "Pharmaceutical compositions and intravitreal drug delivery systems for the treatment of ocular diseases." This patent discloses a biodegradable ocular implant that comprises a biodegradable polymer containing a compound such as Edonentan, or a pharmaceutically acceptable salt thereof. The patent also outlines methods for treating ocular diseases using this biodegradable ocular implant and the preparation methods for the same.

Career Highlights

Angela is currently associated with Perfuse Therapeutics, Inc., where she continues to advance her research and development efforts. Her work focuses on innovative solutions for ocular health, showcasing her commitment to improving patient outcomes.

Collaborations

Angela has collaborated with notable colleagues, including Cheng-Wen Lin and Sevgi Gurkan, to further enhance her research initiatives and drive innovation in her field.

Conclusion

Angela Dawn Glendenning's contributions to ocular disease treatment through her innovative patent and work at Perfuse Therapeutics, Inc. highlight her role as a leading inventor in the pharmaceutical industry. Her dedication to advancing medical technology is commendable and impactful.